Clinical Monitoring Built for MedTech Studies
Bioexcel supports medical device and IVD studies with site feasibility, study start-up, site initiation, clinical monitoring, source-data review, safety oversight, device accountability, protocol-compliance review and site close-out.
Our monitoring approach connects site quality with the study's endpoints, clinical evidence requirements and final regulatory use.
Does Bioexcel Provide Clinical Monitoring for Medical Device Studies?
Yes. Bioexcel provides clinical monitoring for medical device and IVD studies, including site initiation, on-site and remote monitoring, source-data review, consent and eligibility review, safety oversight, device accountability, protocol-deviation review, query follow-up and close-out.
Bioexcel Lifesciences & Research LLP provides clinical monitoring and site-management services for medical device and IVD studies, including site feasibility, initiation, source-data review, safety oversight, device accountability, protocol-compliance review and close-out.
Device Studies Need Device-Specific Oversight
Monitoring may need to account for:
- Device model
- Lot/batch
- Serial number
- Implant details
- Procedure-specific requirements
- Operator training
- Device deficiencies
- Technical success
- Procedural success
- User interaction
- Device accountability
- Reintervention
- Revision
- Imaging
- Long-term follow-up
For IVD studies, additional monitoring considerations may include:
- Sample traceability
- Reference-test results
- Index-test results
- Sample storage
- Test-lot tracking
- Invalid results
- Discordant results
From Site Selection to Study Close-Out
Site Feasibility
- Patient/sample availability
- Investigator expertise
- Infrastructure
- Research experience
- Ethics capability
- Recruitment potential
Output: Shortlisted Site
Site Qualification
- Study suitability
- Required facilities
- Team availability
- Data/source access
- Device/sample handling capability
Output: Qualified Site
Start-Up
- Essential documents
- Ethics package
- Contracts
- Budgets
- Training
- System access
Output: Start-Up Ready Site
Site Initiation
- Protocol
- Device
- Consent
- EDC
- Safety
- Accountability
- Monitoring expectations
Output: Activated Site
Recruitment & Conduct
- Screening
- Enrollment
- Procedures
- Follow-up
- Safety
Output: Live Study Site
Monitoring
- Source data
- Eligibility
- Consent
- Endpoints
- Safety
- Device accountability
- Deviations
Output: Monitoring Findings
Corrective Follow-Up
- Queries
- Deviations
- Missing data
- Documentation gaps
- Training needs
Output: Resolved Site Issues
Close-Out
- Data complete
- Queries closed
- Essential documents complete
- Device accountability reconciled
- Archive requirements addressed
Output: Closed Study Site
What Clinical Monitoring Services Does Bioexcel Provide?
Bioexcel provides site feasibility, site initiation, on-site and remote monitoring, source-data review, consent and eligibility review, safety review, device accountability, protocol-deviation oversight, query follow-up and site close-out for medical device and IVD studies.
What monitoring services does Bioexcel provide?
Bioexcel provides site feasibility, initiation, on-site and remote monitoring, source-data review, safety oversight, device accountability, query follow-up and close-out for medical device and IVD studies.
Can Bioexcel provide only monitoring?
Yes. Sponsors can engage Bioexcel for standalone monitoring or as part of full-service study delivery.
What study types can Bioexcel monitor?
Bioexcel supports monitoring for medical device clinical investigations, PMCF, retrospective PMCF and IVD clinical performance studies.
Select Sites Based on Evidence Delivery, Not Only Reputation
Bioexcel feasibility may assess:
Investigator
- Specialty
- Device experience
- Procedure experience
- Research experience
- Availability
Patient / Sample Pool
- Eligible population
- Monthly volume
- Procedure volume
- Positive/negative sample availability
- Follow-up potential
Infrastructure
- Cath lab
- OT
- Imaging
- Laboratory
- Sample storage
- Research staff
Operations
- Ethics Committee
- Contracting
- Budget
- Data access
- Monitoring access
Can Bioexcel Identify and Qualify Clinical Sites?
Yes. Bioexcel can support site feasibility and qualification based on study population, investigator expertise, infrastructure, recruitment potential, device or IVD requirements and operational readiness.
Confirm That the Site Can Execute the Protocol
A qualification review may consider:
- Study-team availability
- Investigator commitment
- Site workload
- Clinical infrastructure
- Device handling
- Laboratory capability
- Imaging
- Emergency support
- Record quality
- EDC access
- Monitoring access
- Follow-up process
Already Have a Hospital or Investigator?
Bioexcel can support sponsor-selected sites with:
- Feasibility confirmation
- Start-up
- Ethics coordination
- Site initiation
- Monitoring
- Data query follow-up
- Close-out
Can Bioexcel Manage a Sponsor-Selected Site?
Yes. Bioexcel can provide study-management and monitoring support for sponsor-selected hospitals or investigators, depending on the agreed operational scope.
Get the Site Ready Before First Participant In
Bioexcel can coordinate:
- Site document collection
- Investigator CV
- Training records
- Site agreements
- Budget
- Ethics documentation
- Delegation logs
- EDC access
- Device logistics planning
- Monitoring-plan readiness
Align the Site Before Recruitment Begins
SIV training may include:
Protocol
- Objectives
- Eligibility
- Endpoints
- Visits
- Follow-up
Device
- Device description
- Study use
- Handling
- Accountability
- Deficiency reporting
Safety
- Adverse events
- Serious events
- Device relationship
- Reporting timelines
Data
- eCRF
- EDC
- Queries
- Source documentation
Study Operations
- Consent
- Screening
- Recruitment
- Essential documents
- Monitoring
Does Bioexcel Conduct Site Initiation Visits?
Yes. Bioexcel can conduct or coordinate site initiation visits to train investigators and study teams on the protocol, device, safety reporting, EDC, source documentation, recruitment and study procedures.
Define What Will Be Monitored and How
A Monitoring Plan may specify:
- Monitoring frequency
- On-site vs remote activities
- Critical data
- Critical processes
- SDV/SDR strategy
- Safety review
- Device accountability
- Protocol deviation review
- Query process
- Escalation pathway
- Close-out requirements
Review Critical Study Data Against Source Records
Potential activities:
- Informed consent verification
- Eligibility review
- Source-data verification/review
- Primary endpoint review
- Safety review
- Device accountability
- Protocol deviations
- Essential documents
- EDC review
- Query follow-up
Central Review Between Site Visits
Remote monitoring may include:
- EDC review
- Missing-data review
- Query aging
- Visit completion
- Safety status
- Protocol deviations
- Recruitment
- Documentation review where permitted
Can Bioexcel Provide Remote Clinical Monitoring?
Yes. Bioexcel can provide remote monitoring for appropriate study activities and combine it with on-site visits in a hybrid monitoring model where suitable.
Combine On-Site and Remote Oversight
Remote
- Recruitment
- eCRF completion
- Queries
- Follow-up
- Safety status
On-Site
- Consent
- Source records
- Device accountability
- Critical endpoints
Focus Oversight on Critical Data and Processes
Where appropriate, monitoring may prioritize:
- Consent
- Eligibility
- Primary endpoint
- Safety
- Device deficiencies
- Device accountability
- Critical follow-up
- Data affecting regulatory conclusions
Risk-based monitoring should be defined prospectively based on the study.
Participant Protection Starts With Consent
Monitoring can review:
- Correct consent version
- Signatures
- Dates
- Consent before study procedures
- Required re-consent
- Participant copy
- Documentation
Monitoring does not replace investigator responsibility for informed consent.
Confirm the Right Participants Enter the Study
Review may include:
- Inclusion criteria
- Exclusion criteria
- Diagnostic confirmation
- Procedure eligibility
- Required baseline assessments
- Supporting source records
Eligibility errors can directly affect the validity of the final analysis.
Trace Critical eCRF Data Back to the Clinical Record
Source may include:
- Hospital record
- Procedure note
- Operative note
- Cath lab record
- Imaging
- Laboratory reports
- Follow-up records
- Device records
The monitoring approach should be defined according to the protocol and monitoring plan.
Protect the Data That Will Drive the Final Conclusion
Monitoring should prioritize data supporting:
- Primary safety endpoint
- Primary performance endpoint
- Clinical-benefit endpoint
- Follow-up timing
- Device success
- Revision / reintervention
- Diagnostic reference result
Clinical Safety Needs Continuous Oversight
Bioexcel monitoring can review:
- Adverse events
- Serious adverse events
- Device-related events
- Procedure-related events
- Device deficiencies
- Event follow-up
- Required reporting
- EDC consistency
Does Bioexcel Monitor Medical Device Safety Data?
Yes. Bioexcel can review site-level safety documentation, event reporting, relatedness, follow-up and consistency between source records, safety reports and EDC data.
Device Issues Are a Critical MedTech Data Stream
Potential deficiencies:
- Malfunction
- Breakage
- Deployment issue
- Packaging problem
- Labeling issue
- Software/device error
- Unexpected performance issue
Monitoring Should Confirm
Trace Investigational Devices Throughout the Study
Potential review:
- Device receipt
- Lot/batch
- Serial number
- Inventory
- Storage
- Use
- Return
- Destruction
- Reconciliation
Identify and Classify Deviations Consistently
Examples
- Eligibility deviation
- Missed visit
- Follow-up outside window
- Incorrect device use
- Missing procedure
- Consent deviation
- Safety reporting delay
Monitoring and Data Management Should Work Together
Monitor Site Performance Before Recruitment Falls Behind
Track:
- Screening
- Screen failures
- Enrollment
- Recruitment rate
- Follow-up
- Dropout
- Site performance
Central Visibility Across Sites
Suggested metrics:
- Participants enrolled
- Recruitment vs target
- Follow-up completion
- Open queries
- Query aging
- Protocol deviations
- Missing forms
- Safety events
- Monitoring findings
- Action-item status
Monitoring for Diagnostic Performance Studies
Potential IVD monitoring areas:
- Participant eligibility
- Specimen collection
- Sample labeling
- Storage
- Shipment
- Reference testing
- Index testing
- Blinding
- Test lot
- Invalid tests
- Repeat tests
- Discordant results
Does Bioexcel Monitor IVD Clinical Performance Studies?
Yes. Bioexcel supports monitoring of IVD clinical performance studies, including participant/specimen traceability, testing workflows, reference and index results, data quality and protocol compliance.
Historical Data Still Need Source Traceability
Monitoring can verify:
- Patient eligibility
- Device use
- Procedure date
- Long-term follow-up
- Reintervention
- Revision
- Complications
- Primary endpoints
Can Bioexcel Monitor Retrospective PMCF Studies?
Yes. Bioexcel can support source-data review and monitoring of retrospective PMCF studies where hospital records are used to generate structured clinical evidence.
Post-Market Studies Need the Same Evidence Discipline
Bioexcel can monitor:
- Prospective PMCF
- Retrospective PMCF
- Registry programs
- Long-term follow-up
Medical Device Clinical Monitoring in India
Bioexcel supports India-based study monitoring through appropriate clinical operations resources. Potential support:
- Site initiation
- Interim visits
- Remote review
- Source-data review
- Safety
- Close-out
Can Bioexcel Provide Clinical Monitoring Across India?
Yes. Bioexcel supports medical device and IVD clinical monitoring in India through suitable operational resources, depending on site locations and study requirements.
European Clinical Monitoring
Bioexcel can support European monitoring through suitable local resources combined with centralized project oversight. Potential activities:
- SIV
- Interim monitoring
- Remote monitoring
- Source review
- Safety review
- Close-out
Can Bioexcel Support Clinical Monitoring in Europe?
Yes. Bioexcel can coordinate clinical monitoring in Europe through appropriate local resources with centralized Bioexcel project oversight, subject to country and study-specific requirements.
Every Visit Should Produce Clear Actions
- Visit details
- Enrollment
- Consent
- Eligibility
- Source review
- Safety
- Device accountability
- EDC status
- Protocol deviations
- Essential documents
- Findings
- Action items
- Follow-up requirements
Findings Need Closure, Not Just Documentation
Escalate Issues That Could Affect Safety or Evidence Quality
Potential escalation triggers:
- Consent issue
- Major eligibility violation
- Serious safety issue
- Repeated protocol deviations
- Major endpoint-data gap
- Device accountability discrepancy
- Persistent data-quality issue
Escalation pathways should be defined prospectively.
Close the Site With the Data and Documents Complete
Close-out may review:
- Participant status
- Follow-up completion
- Query closure
- Safety completion
- Device accountability
- Essential documents
- Outstanding action items
- Archive requirements
- Site obligations
Does Bioexcel Conduct Site Close-Out?
Yes. Bioexcel can conduct or coordinate close-out activities to confirm study-data completion, outstanding issue resolution, device reconciliation and essential-document readiness.
Clinical Quality Should Flow Into Final Analysis
Monitoring is therefore part of the evidence-generation system, not an isolated activity.
Monitoring From First Site In to Last Site Out
Bioexcel can integrate monitoring with:
- Protocol
- Site start-up
- Recruitment
- Safety
- Data management
- Biostatistics
- CIR
Flexible Monitoring Models
Full-Service CRO
Bioexcel manages the full study.
Monitoring Only
Sponsor or another CRO manages other functions.
Sponsor-Selected Site Monitoring
Bioexcel monitors sites chosen by the sponsor.
Rescue Monitoring
Bioexcel assesses ongoing site-quality issues and implements a corrective monitoring plan.
Can Bioexcel Provide Monitoring Only?
Yes. Clinical monitoring can be provided as a standalone function or integrated with Bioexcel site management, data management, statistics and medical writing.
When a Study Is Already Experiencing Site Problems
Potential issues:
- Poor recruitment
- Excessive deviations
- Missing source data
- Old queries
- Missing follow-up
- Incomplete safety documentation
- Device accountability gaps
Bioexcel Can Assess
Why MedTech Sponsors Use Bioexcel for Clinical Monitoring
Medical Device & IVD Focus
Monitoring reflects device, procedure and specimen-specific risks.
Evidence-Oriented
Critical endpoints receive priority.
Data Integration
Monitoring works directly with EDC and query management.
Flexible Delivery
Full-service or monitoring-only.
India + Europe
Cross-regional operational support.
Sponsor-Selected Sites
Bioexcel can integrate into an existing sponsor site network.
Clinical Monitoring Deliverables
Depending on scope:
- Site Feasibility Questionnaire
- Feasibility Report
- Site Qualification Report
- Monitoring Plan
- SIV Report
- Interim Monitoring Visit Report
- Remote Monitoring Report
- Follow-up letter
- Action-item tracker
- Protocol-deviation tracker
- Recruitment tracker
- Device-accountability review
- Safety follow-up
- Close-Out Visit Report
- Monitoring summary
Clinical Monitoring in Practice
Cardiovascular Device Study
Requirement: Prospective multi-visit study
Bioexcel Role: SIV, interim monitoring, safety review, endpoint verification, close-out
Retrospective PMCF
Requirement: Historical hospital records
Bioexcel Role: Source-record review, eligibility verification and data traceability
IVD Clinical Performance
Requirement: Participant + sample + reference-testing workflow
Bioexcel Role: Site/lab monitoring and specimen traceability
Frequently Asked Questions About Clinical Monitoring
Yes. Bioexcel provides clinical monitoring for medical device and IVD studies, including site initiation, source-data review, safety oversight and close-out.
Bioexcel monitors the critical clinical processes and data that determine whether a MedTech study can support a defensible regulatory conclusion.